Lack of variation of plasma beta-endorphin after clodronate infusion in patients with increased bone resorption
Authors:
Open Access
- 1 August 1993
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 54 (2) , 214-220
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of bone metastases from breast cancer and myeloma with pamidronateEuropean Journal of Cancer and Clinical Oncology, 1991
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)British Journal of Cancer, 1988
- Bone density of the radius, spine, and proximal femur in osteoporosisJournal of Bone and Mineral Research, 1988
- PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)The Lancet, 1988
- Human Plasma β-Endorphin-Like Peptides: A Rapid, High Recovery Extraction Technique and Validation of Radioimmunoassay*The Journal of Clinical Endocrinology & Metabolism, 1983
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysisClinica Chimica Acta, 1972